We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Novel Diagnostic Assay Platform to Fasten Response Time to Emerging Pandemic Situations

By LabMedica International staff writers
Posted on 07 Feb 2023
Print article
Image: A collaborative project aims to deliver an innovative diagnostic platform for fast pandemic responsiveness (Photo courtesy of Clickmer)
Image: A collaborative project aims to deliver an innovative diagnostic platform for fast pandemic responsiveness (Photo courtesy of Clickmer)

The COVID-19 pandemic brought about a health crisis that highlighted severe fragilities within the healthcare sector, including lack of preparedness. In order to reduce vulnerability to future pandemics, there is a need for a large-scale, coordinated and comprehensive health response. Now, a new project aims to establish a diagnostic assay platform that can enable a faster response time during emerging pandemics.

A collaboration project, InfektoFlex, launched by Clickmer Systems (Manchester, UK) and Fraunhofer IMS (Duisburg, Germany) has received a EURO 1.1 million grant to develop an innovative diagnostic platform for fast pandemic responsiveness. The project which is due to commence in spring 2023 aims to establish a novel diagnostic assay platform that can enable a fast response time towards emerging pandemic situations. In the collaboration, Clickmers will be being combined with optical nanosensors, to develop a diagnostic assay platform with superior sensitivity and specificity having a faster response time for the detection of societal relevant emerging pathogens. Clickmers are synthetic antibody analogues that can bind to targets with high specificity and affinity. Optical nanosensors, which are fluorescent in near infrared light, qualify for low signal-to-noise ratio. Upon binding of a pathogen to the detection structure, the fluorescence of the nanosensor changes, thereby enabling measurement of the binding events.

“We are excited to launch the project InfektoFlex with Fraunhofer IMS. The platform will provide a more cost-efficient and time-saving solution, with a reduction in development costs through a more sustainable process compared to the commonly used ELISA assay systems (which require the usage of animal-derived antibodies),” said Dr. Ian Kavanagh, COO of APIS Assay Technologies. “Clickmer Systems will provide an adaptive and innovative diagnostic platform for pandemic responsiveness with higher reproducibility.”

Related Links:
Clickmer Systems 
Fraunhofer IMS 

Gold Supplier
Urinalysis Dipstick Control
Dipper Urinalysis Dipstick Control
Gold Supplier
D-Dimer Rapid Test
Infection Laboratory Test Panels
Silver Supplier
Deepwell Plates
Accumax Deepwell Plates

Print article


Clinical Chem.

view channel
Image: By analyzing urine of patients, it is possible to determine their likelihood of death (Photo courtesy of University of Liverpool)

Urine Test Accurately Predicts End of Life for Lung Cancer Patients

Lung cancer continues to be the leading cause of cancer-related deaths for both men and women around the globe. This deadly disease can affect its victims in various ways, such as through tumor growth... Read more

Molecular Diagnostics

view channel
Image: Biomarkers have shown promise for identifying early risk of pancreatic cancer (Photo courtesy of Pexels)

Biomarker-Based Approach Could Identify Early Risk of Pancreatic Cancer

The incidence of pancreatic cancer is increasing, although the cause of its growing prevalence remains unknown. Even if pancreatic cancer is detected in its early stages, it usually spreads cells throughout... Read more


view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more


view channel
Image: Sampling a single stool using multiple PCR panels can identify more pathogens rapidly (Photo courtesy of Pexels)

PCR Panels for Acute GI Infections Can Lower Costs, Hospitalization and Antibiotic Use

Acute gastroenteritis impacts adults across all age groups and incurs enormous healthcare expenses. Now, a new study comprising 40,000 hospital visits across various geographic locations has revealed that... Read more


view channel
Image: QAi Prostate is an advanced AI-powered prostate cancer diagnosis tool for pathologists (Photo courtesy of Qritive)

AI-Powered Prostate Cancer Diagnosis Tool Accurately Identifies and Classifies Tumors

Prostate adenocarcinoma is the most prevalent form of prostate cancer, representing around 90% of all prostate cases, and is also the second most commonly occurring cancer in men, demonstrating a steady... Read more


view channel
Image: The Miro Canvas system is a revolutionary digital microfluidics platform that automates NGS library prep. (Photo courtesy of Miroculus)

Integra Biosciences Acquires Biotechnology Specialist Miroculus to Advance Genomics Discoveries

Next-generation sequencing (NGS) is a rapid and inexpensive approach for examining the genome - the entire set of an organism's DNA. It has gained immense popularity since its inception almost two decades... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.